Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery
Etriki, R., Abd Ellatif, H., Sayouh, E., Mohammed, A. (2022). Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery. EKB Journal Management System, 87(1), 1658-1665. doi: 10.21608/ejhm.2022.227712
Rabei Gheth Salem Etriki; Howaida Kamal Abd Ellatif; Ekram Fawzy Sayouh; Ahmed Mosallam Mohammed. "Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery". EKB Journal Management System, 87, 1, 2022, 1658-1665. doi: 10.21608/ejhm.2022.227712
Etriki, R., Abd Ellatif, H., Sayouh, E., Mohammed, A. (2022). 'Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery', EKB Journal Management System, 87(1), pp. 1658-1665. doi: 10.21608/ejhm.2022.227712
Etriki, R., Abd Ellatif, H., Sayouh, E., Mohammed, A. Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery. EKB Journal Management System, 2022; 87(1): 1658-1665. doi: 10.21608/ejhm.2022.227712

Spinal Anesthesia Using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for Day case Surgery

The Egyptian Journal of Hospital Medicine
Article 111, Volume 87, Issue 1, April 2022, Page 1658-1665  XML PDF (642.11 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2022.227712
View on SCiNiTO View on SCiNiTO
Authors
Rabei Gheth Salem Etriki email ; Howaida Kamal Abd Ellatif; Ekram Fawzy Sayouh; Ahmed Mosallam Mohammed
Abstract
Background: Day-case spinal anesthesia with short-acting local anesthetics such as hyperbaric prilocaine, has a short duration of action and the transient neurological symptoms (TNS) incidence is low.
 Objective: The present study aimed to compare spinal anesthesia using hyperbaric prilocaine 2% and hyperbaric bupivacaine 0.5% for day case surgery.
Patients and Methods: This Prospective randomized controlled double-blind clinical trial study was carried out on 66 patients of both sexes scheduled for day case surgery under spinal anesthesia, They were divided into two groups; group P: received 60mg hyperbaric prilocaine 2%; group C: received 15mg hyperbaric bupivacaine 0.5%.
Results: The prilocaine group showed a faster onset time of sensory (1.95 ± 0.36 min) and motor block (4.87 ± 0.7 min) and shorter time to reach maximal sensory block level(p < 0.001). Prilocaine group also provides a shorter duration time of sensory (92.4 ± 2.5min) and motor block (110.7 ± 8.8min) than that of the bupivacaine group (207.6 ± 10.9&253.9 ± 19.8 min) respectively). Prilocaine group showed a statistically significant shorter time to sit (113.3 ±7.7min), stand (121.8±10.5min), walk unassisted (130.7±7.8 min) and void spontaneously (256.4±21.5 min) compared to the corresponding times in the bupivacaine group, where the time to sit, stand, walk unassisted and void spontaneously were (279.1±14.0 min) (285.5±10.9min), (301.8±13.9min), (345.4±24.5min) respectively.
Conclusions: Hyperbaric prilocaine provides faster onset time, shorter duration of action, and earlier patient recovery in ambulatory surgery compared to hyperbaric bupivacaine in day-case surgery.
 
Keywords
Spinal Anesthesia; Hyperbaric; Prilocaine 2%; Bupivacaine 0.5%
Statistics
Article View: 322
PDF Download: 964